CDC Nominee Faces Uncertain Path After Senate Hearing; Northeast Florida Public Health Role in Focus

President Donald Trump's nominee to lead the Centers for Disease Control and Prevention faced a difficult confirmation hearing before the U.S. Senate Health, Education, Labor and Pensions Committee on July 15, with key senators from both parties expressing skepticism about her ability to lead the nation's premier public health agency. Dr. Erica Schwartz, a former Navy admiral and deputy surgeon general, appeared unable to secure sufficient support to advance her nomination despite pledging to "never betray the science."

Committee Chairman Bill Cassidy, R-La., told Schwartz at the hearing's conclusion that he believed administration officials had overprepared her and that her responses missed the mark. "I felt like you were always trying not to answer my question, which was disappointing," Cassidy said after more than two hours of testimony. With Republicans holding a thin 12-11 majority on the committee, any single Republican joining with unanimous Democratic opposition could block the nomination.

What's happening

During the July 15, 2026 confirmation hearing, Schwartz testified before the Senate Health, Education, Labor and Pensions Committee regarding her nomination to become CDC director. The hearing covered multiple public health topics including vaccine safety, disease surveillance systems, and the agency's relationship with state and local health departments.

Chairman Cassidy repeatedly questioned Schwartz about whether she would follow the example of former CDC Director Susan Monarez, who testified last year that she was fired after refusing to pre-approve vaccine recommendations or fire career officials without cause. Cassidy stated in his opening remarks that "we need unbiased leaders who make decisions based upon science, not politics or ideology, and are committed to protecting children's health."

Schwartz committed during questioning that she "accept(s) that evidence" that vaccines don't cause autism and affirmed that mRNA vaccine "technology is safe and effective." She outlined priorities including "restoring trust in public health institutions through radical transparency and unwavering scientific integrity" and working to "modernize the CDC into a near real-time public health enterprise."

Missouri Republican Sen. Josh Hawley secured Schwartz's commitment to investigate potential health implications for people living near data centers and to ensure the CDC collects comprehensive abortion data from all states through the Abortion Reporting System, which is currently voluntary. Washington Democratic Sen. Patty Murray questioned Schwartz about the ongoing cyclosporiasis outbreak and the Trump administration's decision in July 2025 to make reporting of the parasitic infection optional rather than mandatory.

Impact on Florida disease surveillance

The CDC director's approach to disease monitoring directly affects Northeast Florida's ability to track and respond to health threats. The agency works closely with the Florida Department of Health, which operates county health departments throughout Duval, St. Johns, Clay, Nassau, Baker, Putnam, and Flagler counties that serve as the frontline for infectious disease surveillance and response.

Under federal law, the CDC establishes the National Notifiable Diseases Surveillance System, which state health departments use to track reportable conditions. When the CDC makes disease reporting optional rather than mandatory—as it did with cyclosporiasis in July 2025—states have discretion over whether to continue surveillance. This directly impacts the ability of Florida's county health departments to detect foodborne illness outbreaks that could affect the region's restaurants, produce distributors, and agricultural operations.

The cyclosporiasis outbreak mentioned in the hearing is particularly relevant to Northeast Florida's agricultural sector. The parasitic infection is typically associated with fresh produce, and Florida is a major producer and distribution point for fruits and vegetables moving through the region's logistics infrastructure. As of the hearing date, more than 7,000 confirmed or under-investigation cases and over 100 hospitalizations had been reported nationally with no single cause identified. Weakened surveillance systems make it harder to trace outbreak sources to specific farms, packing facilities, or distribution centers—information critical to protecting public health and the region's agricultural economy.

Schwartz testified that tracking outbreaks "domestically and also internationally" is "one of the core missions" of the CDC but did not commit to reinstating mandatory cyclosporiasis reporting, saying only that she would work with Sen. Murray to understand why reporting became optional and what options exist going forward.

Federal-local public health relationship

Schwartz's stated priority to make local, state, and tribal governments the "operational backbone of American public health" signals a potential shift in how federal resources and guidance flow to Northeast Florida's seven county health departments. These departments currently rely on CDC funding streams, technical assistance, and disease surveillance infrastructure to operate programs ranging from immunization clinics to environmental health inspections.

Florida's county health departments function under the state Department of Health's supervision but depend on federal grants that pass through the CDC for significant portions of their budgets. Programs that provide services in Northeast Florida—including childhood immunization initiatives, tuberculosis control, HIV/AIDS prevention, and emergency preparedness—typically combine state general revenue with federal CDC cooperative agreements. Any reorganization of CDC priorities or funding mechanisms under new leadership would directly affect the services available to residents in the seven-county region.

The CDC also provides technical expertise and laboratory support that smaller health departments cannot maintain independently. When unusual disease clusters appear in Northeast Florida—such as mosquito-borne illnesses during summer months or foodborne outbreaks linked to restaurants—county health departments work with the state epidemiology office and the CDC to investigate. The responsiveness and scientific rigor of CDC support affects how quickly local officials can identify threats and implement control measures.

Chairman Cassidy's focus on whether Schwartz would protect career CDC scientists from political interference relates directly to this technical support function. Career epidemiologists, laboratory scientists, and public health advisors staff the teams that assist Florida during outbreaks. If political considerations influence CDC recommendations or staff decisions, the scientific credibility of guidance provided to Northeast Florida's health departments could be compromised.

Vaccine policy implications

Schwartz's testimony on vaccine safety carries weight for Northeast Florida's immunization programs. Florida's county health departments provide childhood vaccines through the Vaccines for Children program, a federally funded CDC initiative that supplies vaccines to eligible children at no cost. The program serves thousands of children in Northeast Florida whose families meet income eligibility requirements or lack insurance coverage for immunizations.

The CDC's Advisory Committee on Immunization Practices develops the vaccine schedules that Florida's schools use for enrollment requirements and that healthcare providers follow for routine preventive care. The committee's independence from political pressure—the issue Cassidy raised regarding former director Monarez—determines whether vaccine recommendations reflect scientific evidence or other considerations. School systems in St. Johns, Clay, and Duval counties follow state law that incorporates CDC immunization schedules, so any politicization of vaccine recommendations would directly affect which vaccines children need for school attendance.

Schwartz affirmed the safety and effectiveness of mRNA vaccines and stated that vaccines don't cause autism, addressing concerns that have circulated in some communities and online forums. Northeast Florida's healthcare providers, including Baptist Health, UF Health Jacksonville, Ascension St. Vincent's, and Mayo Clinic's Jacksonville campus, rely on CDC guidance to counsel patients about vaccines. Clear, science-based recommendations from the CDC help these institutions maintain public confidence in immunization programs that protect the region's population from preventable diseases.

The broader debate over vaccine policy also affects Northeast Florida's military installations. Naval Station Jacksonville, Naval Station Mayport, and personnel from Kings Bay Naval Submarine Base who live in the region are subject to military immunization requirements. While the Department of Defense sets its own vaccine policies, it typically aligns with CDC recommendations. Confusion or controversy over CDC vaccine guidance can complicate military health operations in the region.

What happens next

The Senate Health, Education, Labor and Pensions Committee has not announced when it will vote on Schwartz's nomination. Under Senate rules, the committee must approve the nomination before it can advance to the full Senate for a confirmation vote. Given Chairman Cassidy's stated disappointment with Schwartz's responses and the narrow 12-11 Republican majority on the committee, the nomination's path forward is uncertain.

If the committee does not approve Schwartz, President Trump would need to nominate a different candidate to lead the CDC, extending the period during which the agency operates without a Senate-confirmed director. If Schwartz is approved by the committee and confirmed by the full Senate, her priorities—including how she handles disease surveillance systems, vaccine policy, and relationships with state health departments—would shape federal public health policy affecting Northeast Florida for the duration of her tenure.

Residents and healthcare providers in Northeast Florida who want to track the nomination can monitor the Senate Health, Education, Labor and Pensions Committee's schedule for any announced vote. The committee's website posts hearing videos, witness testimony, and vote results. Florida's two U.S. senators do not serve on this committee, so they would vote only if the nomination reaches the full Senate floor.

The CDC nomination battle unfolds as Northeast Florida continues its rapid population growth, adding tens of thousands of residents annually who will rely on public health infrastructure. Whether the federal agency responsible for disease surveillance, vaccine policy, and health emergency response operates with scientific credibility and adequate resources affects the region's ability to protect its expanding population from health threats. The questions raised in Schwartz's confirmation hearing about scientific integrity, disease monitoring, and political interference remain open as senators decide whether to advance her nomination.